Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose-dense AC-T vs. Paclitaxel + Carboplatin in TNBC
NCT01378533Phase 3Unknown
- Sponsor
- Chinese Academy of Medical Sciences
- Start
- May 2011
- Primary completion
- May 2013
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 3 trial of carboplatin in triple negative breast cancer (TNBC), sponsored by Chinese Academy of Medical Sciences. Status: unknown.
02
Drugs
carboplatin
03
Conditions
triple negative breast cancer (TNBC)
Beyond the preview
Go deeper on NCT01378533.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01378533.